S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
NASDAQ:KRYS

Krystal Biotech (KRYS) News Today

$121.79
-2.41 (-1.94%)
(As of 06/5/2023 ET)
Compare
Today's Range
$120.46
$127.02
50-Day Range
$78.48
$124.20
52-Week Range
$49.17
$127.02
Volume
325,973 shs
Average Volume
242,098 shs
Market Capitalization
$3.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$134.00
Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.



KRYS Media Mentions By Week

KRYS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRYS
News Sentiment

0.85

0.55

Average
Medical
News Sentiment

KRYS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRYS Articles
This Week

9

4

KRYS Articles
Average Week

SourceHeadline
finance.yahoo.com logoKrystal Biotech to Present at Upcoming Investor Conferences
finance.yahoo.com - June 5 at 10:25 AM
marketbeat.com logoCredit Suisse AG Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
marketbeat.com - June 5 at 9:20 AM
finance.yahoo.com logoUp 48% in 2023, Is This Biotech Stock a Buy?
finance.yahoo.com - June 3 at 9:56 AM
MarketBeat logoKrystal Biotech, Inc. (NASDAQ:KRYS) Insider Suma Krishnan Sells 25,000 Shares of Stock
americanbankingnews.com - June 3 at 8:02 AM
benzinga.com logoThinking about buying stock in Krystal Biotech, Axsome Therapeutics, 89bio, Scpharmaceuticals, or Decibel Therapeutics?
benzinga.com - June 2 at 8:24 PM
marketbeat.com logoSuma Krishnan Sells 25,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock
marketbeat.com - June 2 at 8:04 PM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Takes Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
marketbeat.com - June 1 at 5:56 AM
marketbeat.com logoKrystal Clear: Krystal Biotech Clears Resistance in Good Volume
marketbeat.com - May 30 at 7:38 AM
finance.yahoo.com logoAre Investors Undervaluing Krystal Biotech, Inc. (NASDAQ:KRYS) By 41%?
finance.yahoo.com - May 29 at 4:05 PM
MarketBeat logoChardan Capital Weighs in on Krystal Biotech, Inc.'s FY2023 Earnings (NASDAQ:KRYS)
americanbankingnews.com - May 27 at 2:36 AM
MarketBeat logoKrystal Biotech (NASDAQ:KRYS) Price Target Increased to $145.00 by Analysts at Stifel Nicolaus
americanbankingnews.com - May 26 at 6:28 AM
msn.com logoStifel Maintains Krystal Biotech (KRYS) Buy Recommendation
msn.com - May 25 at 8:46 AM
marketbeat.com logoFY2023 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By Chardan Capital
marketbeat.com - May 25 at 6:35 AM
MarketBeat logoKathryn Romano Sells 25,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock
americanbankingnews.com - May 25 at 5:44 AM
MarketBeat logoDaniel Janney Sells 50,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock
americanbankingnews.com - May 25 at 5:44 AM
MarketBeat logoKathryn Romano Sells 28,428 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock
americanbankingnews.com - May 25 at 5:44 AM
marketbeat.com logoKrystal Biotech, Inc. (NASDAQ:KRYS) Position Trimmed by Citigroup Inc.
marketbeat.com - May 25 at 5:34 AM
MarketBeat logoKrystal Biotech (NASDAQ:KRYS) Price Target Raised to $139.00
americanbankingnews.com - May 25 at 4:14 AM
MarketBeat logoFY2027 EPS Estimates for Krystal Biotech, Inc. Boosted by William Blair (NASDAQ:KRYS)
americanbankingnews.com - May 25 at 2:30 AM
MarketBeat logoQ3 2023 EPS Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) Raised by Analyst
americanbankingnews.com - May 25 at 1:56 AM
finanznachrichten.de logoOption Care Health, Inc.: Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK
finanznachrichten.de - May 24 at 7:42 AM
msn.com logoOption Care, Amedisys in pact to offer Krystal Biotech’s skin disorder therapy
msn.com - May 24 at 7:42 AM
MarketBeat logoKrystal Biotech, Inc. (NASDAQ:KRYS) Forecasted to Post Q3 2023 Earnings of ($1.25) Per Share
americanbankingnews.com - May 24 at 6:32 AM
marketbeat.com logoQ3 2023 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By HC Wainwright
marketbeat.com - May 24 at 6:00 AM
MarketBeat logoHC Wainwright Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $139.00
americanbankingnews.com - May 24 at 4:30 AM
MarketBeat logoKrystal Biotech (NASDAQ:KRYS) Price Target Raised to $118.00
americanbankingnews.com - May 24 at 2:34 AM
MarketBeat logoKrystal Biotech (NASDAQ:KRYS) Shares Gap Up After Analyst Upgrade
americanbankingnews.com - May 24 at 2:02 AM
finance.yahoo.com logoOption Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
finance.yahoo.com - May 23 at 4:40 PM
msn.com logoGoldman Sachs Maintains Krystal Biotech (KRYS) Buy Recommendation
msn.com - May 23 at 6:39 AM
msn.com logoB of A Securities Maintains Krystal Biotech (KRYS) Buy Recommendation
msn.com - May 23 at 6:39 AM
marketbeat.com logoFY2027 EPS Estimates for Krystal Biotech, Inc. Raised by William Blair (NASDAQ:KRYS)
marketbeat.com - May 23 at 6:25 AM
msn.com logoUnlocking a $750 Million Opportunity: Krystal Biotech's Vyjuvek and its Potent Impact on Dystrophic Epidermolysis Bullosa Treatment
msn.com - May 22 at 10:48 PM
msn.com logoKrystal Biotech announces $160M private placement
msn.com - May 22 at 5:48 PM
markets.businessinsider.com logoCSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech
markets.businessinsider.com - May 22 at 5:48 PM
finance.yahoo.com logoWhy Shares of Krystal Biotech Are Rising Monday
finance.yahoo.com - May 22 at 5:48 PM
marketwatch.com logoKrystal Biotech Shares Rise 13% After $160M Private Placement Equity
marketwatch.com - May 22 at 12:47 PM
markets.businessinsider.com logoAnalyst Expectations for Krystal Biotech's Future
markets.businessinsider.com - May 22 at 12:47 PM
finance.yahoo.com logoFDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder
finance.yahoo.com - May 22 at 12:47 PM
MarketBeat logoGuggenheim Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $130.00
americanbankingnews.com - May 22 at 9:24 AM
MarketBeat logoKrystal Biotech (NASDAQ:KRYS) Price Target Raised to $148.00
americanbankingnews.com - May 22 at 8:30 AM
finance.yahoo.com logoKrystal Biotech Announces $160 Million Private Placement Equity Financing
finance.yahoo.com - May 22 at 7:47 AM
marketbeat.com logoVictory Capital Management Inc. Buys 35,732 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
marketbeat.com - May 21 at 5:52 AM
msn.com logoKrystal Biotech stock rises after FDA approves treatment for rare skin disease
msn.com - May 20 at 11:12 PM
msn.com logoU.S. FDA approves Krystal Biotech's skin-disorder gene therapy
msn.com - May 20 at 11:12 PM
seekingalpha.com logoKrystal gains FDA nod for topical gene therapy for rare skin disorder
seekingalpha.com - May 19 at 10:09 PM
finance.yahoo.com logoKrystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
finance.yahoo.com - May 19 at 5:09 PM
finance.yahoo.com logoUPDATE 1-U.S. FDA approves Krystal Biotech's skin disorder gene therapy
finance.yahoo.com - May 19 at 5:09 PM
marketbeat.com logo
marketbeat.com - May 19 at 12:16 PM
msn.com logoKrystal Biotech: A Promising Gene Therapy Innovator
msn.com - May 18 at 4:06 PM
MarketBeat logoKrystal Biotech, Inc. (NASDAQ:KRYS) Sees Large Decline in Short Interest
americanbankingnews.com - May 17 at 4:10 AM
Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:KRYS) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -